Restorative Effects of Sleep on Everyday Health and Wellbeing: A Treatment Study
A legfontosabb adatok
- Ki végzi
- University of Notre Dame
- Hol
- Notre Dame (Egyesült Államok)A helyszín megnézése
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 115 fő, tervezett
- Kezdés
- 2025. szept. 29.
- Várható befejezés
- 2027. aug. 31.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoport
- A vizsgált kezelések
- Cognitive Behavioral Therapy for Insomnia
- A regiszteradat frissítve
- 2026. április 23.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for adults with chronic insomnia who speak English. Half will sleep less than 6 hours a night and half 6 or more hours.
- Életkor
- 18 years or older
- Nem
- All sexes
- A betegség stádiuma
- Chronic insomnia that meets DSM-5 criteria for Insomnia Disorder, checked by a screener and a short clinical interview.
- Korábbi kezelés
- People currently taking sleep medication, medication for hormone (endocrine) problems, or medication that affects sleep or cortisol cannot join.
A részvétel fő kizáró okai
- Sleep disorders other than insomnia, or hormone (endocrine) disorders
- Shift work or another extreme sleep schedule
- Heavy alcohol or drug use, or serious mental illness
- Chronic medical conditions that less sleep could make worse
- Women who are pregnant, breastfeeding, or in the stage just before menopause
A regiszter feltételei, szó szerint
Mind a 14 feltétel megnézéseKevesebb
Ki vehet részt
- At least 18-years-old
- Speaks English
- Meets DSM-5 criteria for Insomnia Disorder, determined through initial screener than verified during brief clinical interview (at intake)
Ki nem vehet részt
- Currently taking sleep medication
- Currently taking medication for endocrine dysfunction
- Currently taking medication that interferes with sleep or cortisol levels
- Sleep disorders other than Insomnia
- Endocrine disorders
- Serious mental illness
- Chronic medical conditions (which may be exacerbated by sleep restriction)
- Extreme sleep schedule (i.e. shift workers)
- Excessive alcohol/substance use or AUD/SUD
- Pregnant or nursing women
- Women in the peri-menopausal stage due to irregular menses and fluctuations in sex hormones
Ez a vizsgálat jelenleg itt érhető el: Egyesült Államok.
- University of Notre DameNotre Dame, Egyesült ÁllamokContact: Ivan VargasRésztvevőt keres
A vizsgálatról
Mit akar kideríteni a vizsgálat
The purpose of this study is to evaluate the mechanisms through which Cognitive Behavioral Therapy for Insomnia (CBT-I) leads to improvements in sleep and sleep-related daytime outcomes, specifically as it relates to cortisol and the hypothalamic-pituitary-adrenal (HPA) axis, the body's primary stress response system. The primary research aims are: 1) To determine whether changes in cortisol functioning are related to improvements in sleep consolidation (4-week CBT-I), sleep duration (10-week CBT-I) or both, AND 2) to examine whether these improvements are more pronounced among individuals with insomnia and short sleep duration (compared to insomnia with 'normal' sleep duration).This study will recruit individuals with chronic insomnia: half with reported short sleep duration (less than 6 hours of sleep on an average night) and half with reported non-short sleep duration (6 or more hours per night). Participants will complete an in-lab assessment on four different occasions. During the first visit, they will confirm eligibility, complete an online survey, complete an in-lab stress task (with saliva samples), and provide a hair sample to measure cortisol (a hormone). They will then be sent home with a home sleep test as a final eligibility check (to rule out sleep disorders other than insomnia), an actigraphy watch to measure their sleep, and collection tubes to provide saliva samples to measure cortisol. We will then track the participants' sleep using online daily diaries and actigraphy for four week. Following the 4-week baseline period, participants will come in for a second in-lab visit (same procedures as the first visit) and then be randomized to receive either four or ten weeks of Cognitive Behavioral Therapy for Insomnia (CBT-I). CBT-I is a empirically supported behavioral treatment for insomnia and the first-line treatment for chronic insomnia. Sleep patterns and insomnia symptoms will continue to be monitored via diaries during the intervention phase. The third visit will take place once the participant has completed the intervention and the fourth visit will occur three months following the third visit (3 months post-treatment). The 3rd and 4th visits will again replicate the same procedures conducted during the initial lab visit.
A vizsgálat 2 csoportja
- 4-Week CBT-IA vizsgált kezelés
Participants in this arm will receive 4 weeks of CBT-I.
Kezelés: Cognitive Behavioral Therapy for Insomnia
- 10-Week CBT-IA vizsgált kezelés
Participants in this arm will receive 10 weeks of CBT-I.
Kezelés: Cognitive Behavioral Therapy for Insomnia
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Effects of CBT-I on Hypothalamic-Pituitary-Adrenal (HPA)-Axis Functioning in Participants With Chronic Insomnia
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- A regiszteradat frissítve
- 2026. április 23.